3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
2354
Neoplasms
1704
Prostatic Neoplasms
1192
Lung Neoplasms
922
Colorectal Neoplasms
884
Carcinoma, Non-Small-Cell Lung
866
Leukemia, Myeloid, Acute
593
Pancreatic Neoplasms
574
Multiple Myeloma
551
Carcinoma, Hepatocellular
516
Brain Neoplasms
515
Neoplasm Metastasis
461
Head and Neck Neoplasms
457
Melanoma
414
Ovarian Neoplasms
412
Glioblastoma
402
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Stomach Neoplasms
376
Uterine Cervical Neoplasms
362
Squamous Cell Carcinoma of Head and Neck
362
Rectal Neoplasms
342
Recurrence
335
Sarcoma
324
Hematologic Neoplasms
324
Colonic Neoplasms
321
Lymphoma
320
Triple Negative Breast Neoplasms
289
Carcinoma, Renal Cell
283
Urinary Bladder Neoplasms
281
Glioma
280
Interventions
Interleukin 1 Receptor Antagonist Protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Early Stage Triple Negative ER Low Breast Cancer
×
1 year
×
Clear all
NCT06710197
2026-03-05
OZM-034
University Health Network, Toronto
Phase 2
Withdrawn